Search
for
Sort by
Research 571–600 of 1000+
- The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata
- Post‐COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- De novo single-nucleotide and copy number variation in discordant monozygotic twins reveals disease-related genes
- Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation
- Skin disease in pregnancy
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- Alteration of Ethanol Drinking in Mice via Modulation of the GABAA Receptor with Ganaxolone, Finasteride, and Gaboxadol
- The Clinical Presentation of Systemic Lupus Erythematosus
- Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
- Skin organoids: A new human model for developmental and translational research
- Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations
- Differential diagnosis of hair loss in children. Differentialdiagnose des Haarausfalls bei Kindern
- Diagnostic approach to low‐renin hypertension
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Scalp Itch: A Systematic Review
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Lupus panniculitis clinically simulating alopecia areata
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- Enoxaparin-induced alopecia in patients with cerebral venous thrombosis
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Systematic review of platelet‐rich plasma in treating alopecia: Focusing on efficacy, safety, and therapeutic durability
- Biallelic HEPHL1 variants impair ferroxidase activity and cause an abnormal hair phenotype
- Current Understanding of the Pathways Involved in Adult Stem and Progenitor Cell Migration for Tissue Homeostasis and Repair
- Hair Loss in Children
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017